ONCODESIGN Logo

ONCODESIGN

Develops therapeutic and diagnostic solutions for resistant and metastatic cancers.

ALONC | PA

Overview

Corporate Details

ISIN(s):
FR0011766229
LEI:
9695004HPDBVG72O8851
Country:
France
Address:
20 RUE JEAN MAZEN, 21000 DIJON

Description

Oncodesign Precision Medicine is a biotechnology company specializing in precision medicine. Its mission is to develop and deliver innovative therapeutic and diagnostic solutions to treat resistant and metastatic cancers. The company utilizes a unique, patient-centric model and a proprietary technology platform to discover and advance effective treatments. This approach is centered on translational thinking, aiming to address the challenges of therapeutic resistance and metastasis evolution by focusing on unmet patient needs.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2018-05-18 20:02
Communiqués au titre de l'obligation d'information permanente / Activité de l'é…
French 724.2 KB
2018-04-30 17:45
Communiqués de mise à disposition de documents / Modalités de mise à dispositio…
French 498.8 KB
2018-04-23 18:00
Communicated under the obligation to provide permanent information / Other comm…
English 611.5 KB
2018-04-23 18:00
Communiqués au titre de l'obligation d'information permanente / Autres communiq…
French 720.4 KB
2018-03-27 19:00
Communiqués au titre de l'obligation d'information permanente / Activité de l'é…
French 740.4 KB
2018-03-27 19:00
Communicated under the obligation to provide permanent information / Activity o…
English 724.8 KB
2018-03-06 18:09
Information relative au nombre total de droits de vote et d'actions composant l…
French 777.4 KB
2018-01-10 18:00
Rachat d'actions / Contrat de liquidité Information relative au contrat de liqu…
French 563.5 KB
2017-12-05 18:00
Communicated under the obligation to provide permanent information / Activity o…
English 627.4 KB
2017-12-05 18:00
Communiqués au titre de l'obligation d'information permanente / Activité de l'é…
French 738.9 KB
2017-11-15 18:00
Communiqués au titre de l'obligation d'information permanente / Activité de l'é…
French 737.4 KB
2017-11-15 18:00
Communicated under the obligation to provide permanent information / Activity o…
English 627.6 KB
2017-10-18 18:00
Communicated under the obligation to provide permanent information / Activity o…
English 405.3 KB
2017-10-18 18:00
Communiqués au titre de l'obligation d'information permanente / Activité de l'é…
French 549.1 KB
2017-10-05 08:00
Communiqués au titre de l'obligation d'information permanente / Activité de l'é…
French 420.9 KB

Automate Your Workflow. Get a real-time feed of all ONCODESIGN filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ONCODESIGN

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ONCODESIGN via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.